Kenvue (KVUE) Q2 (USD): Adj. EPS 0.31 (exp. 0.32), Revenue 3.96bln (exp. 3.97bln)

A marginal miss on both lines, within a cent on EPS and within a rounding error on revenue, places this in the category of consumer-staples prints where the headline numbers matter less than the composition underneath. For recently separated consumer health names of this kind, the established pattern is that the market reacts to organic growth versus pricing, category volumes in the core brands, and margin trajectory rather than to small beats or misses on consensus. Staples prints with misses of this size have historically produced muted single-name moves unless guidance shifts, so the follow-on items are the outlook commentary, any change to the full-year framework, and whether the shortfall sits in volume or in mix and promotion spend. The call and the detail on emerging-market demand and private-label pressure tend to carry more signal than the print itself. As an EU-session release on a US-listed name, initial price formation comes in thin pre-market liquidity and often retraces or extends once the full text and call are absorbed.